Profound Medical Inc. is a commercial‑stage medical technology company headquartered in Mississauga, Ontario, dedicated to advancing care for prostate cancer and benign prostatic hyperplasia (BPH). Its flagship product, TULSA‑PRO®, is an FDA‑cleared, AI‑powered, MRI‑guided robotic ablation system that performs incision‑free prostate tissue ablation with real‑time precision and customizable treatment plans. By integrating cutting‑edge imaging, artificial intelligence, and robotic control, TULSA‑PRO® delivers clinically effective outcomes while preserving patients’ quality of life—setting a new standard in minimally invasive prostate therapy. The platform is fully reimbursable, enabling widespread adoption by clinicians seeking advanced, patient‑centric solutions.
The Corporate Counsel, Contracts & Commercial Affairs provides broad legal support across the organization, with primary responsibility for contract law, commercial contracting, and the full lifecycle management of sales and corporate agreements.
Profound Medical Inc. is a commercial‑stage medical technology company headquartered in Mississauga, Ontario, dedicated to advancing care for prostate cancer and benign prostatic hyperplasia (BPH). Its flagship product, TULSA‑PRO®, is an FDA‑cleared, AI‑powered, MRI‑guided robotic ablation system that performs incision‑free prostate tissue ablation with real‑time precision and customizable treatment plans. By integrating cutting‑edge imaging, artificial intelligence, and robotic control, TULSA‑PRO® delivers clinically effective outcomes while preserving patients’ quality of life—setting a new standard in minimally invasive prostate therapy. The platform is fully reimbursable, enabling widespread adoption by clinicians seeking advanced, patient‑centric solutions.
Profound Medical Inc.